| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |